Skip to main content
    M

    Matinas BioPharma Holdings Inc (MTNB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.95
    +0.05 (+5.11%)

    Market Cap: $881,570

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Matinas BioPharma Holdings Inc (MTNB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Matinas BioPharma Holdings are Scinai Immunotherapeutics (SCNI), Kairos Pharma (KAPA) and Bone Biologics (BBLG). By market cap, Matinas BioPharma Holdings ranks 11th of the 13 companies on this page; Purple Biotech (PPBT) is the largest at $2.65M.

    Peer Comparison

    MTNB's ROIC of -187.9% is above the peer median of -289.9%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Matinas BioPharma Holdings (MTNB)$8815700.9xN/A0.0%-187.9%-100.0%0.00%
    Scinai Immunotherapeutics Ltd (SCNI)$1.05MN/AN/A-80.1%N/A572.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Bone Biologics Corp (BBLG)$1.10MN/AN/A0.0%N/A0.0%0.00%
    Silexion Therapeutics Corp (SLXN)$1.29MN/A5.9x0.0%N/A0.0%0.00%
    BioRestorative Therapies Inc (BRTX)$2.06MN/A70.3x0.0%-289.9%-7.3%0.00%
    Oragenics Inc (OGEN)$906900N/AN/A0.0%-656.1%-91.3%0.00%
    Scisparc Ltd (SPRC)$869840N/AN/A0.0%N/A-38.4%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)$1.82MN/A1.7x0.0%N/A-32.5%0.00%
    Virax Biolabs Group Limited Ordinary Shares (VRAX)$823940N/A14.3x0.0%N/A685.0%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    GeoVax Labs Inc (GOVX)$928290N/AN/A0.0%N/A-100.0%0.00%
    Peer median$1.19MN/A10.1x0.0%-289.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Matinas BioPharma Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Scinai Immunotherapeutics Ltd (SCNI)
    Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune...
    SCNI competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Bone Biologics Corp (BBLG)
    Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using recombinant human protein.
    BBLG competitors
    Silexion Therapeutics Corp (SLXN)
    Biomotion Sciences (SLXN) is a forward-thinking biotechnology firm specializing in regenerative medicine...
    SLXN competitors
    BioRestorative Therapies Inc (BRTX)
    BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue...
    BRTX competitors
    Oragenics Inc (OGEN)
    Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
    OGEN competitors
    Scisparc Ltd (SPRC)
    SciSparc Ltd., a specialized clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules.
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
    60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention...
    SXTP competitors
    Virax Biolabs Group Limited Ordinary Shares (VRAX)
    Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE...
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    GeoVax Labs Inc (GOVX)
    GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified...
    GOVX competitors

    Frequently Asked Questions About MTNB

    Who are Matinas BioPharma Holdings' main competitors?

    The companies most similar to Matinas BioPharma Holdings include Scinai Immunotherapeutics (SCNI), Kairos Pharma (KAPA), Bone Biologics (BBLG), Silexion Therapeutics (SLXN) and BioRestorative Therapies (BRTX), listed from the closest match.

    Who is Matinas BioPharma Holdings' biggest competitor?

    Purple Biotech (PPBT) is the largest of the similar companies at $2.65M; Scinai Immunotherapeutics (SCNI) is the closest match by business profile, size, sector and industry.

    How does MTNB stock compare with its competitors?

    MTNB's net margin is 0.0% against a peer median of 0.0%.

    Which of Matinas BioPharma Holdings' competitors pays a higher dividend?

    Matinas BioPharma Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Matinas BioPharma Holdings bigger than its competitors?

    No. Matinas BioPharma Holdings is 11th by market cap among the 13 companies on this page; the largest is Purple Biotech (PPBT) at $2.65M.